Vinothkumar Rajan

Vinothkumar Rajan

Auto-generated profile, based on publicly available information

Vinothkumar Rajan

Biological Sciences, Sunnybrook Research Institute

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
Antony Ceasar StanislausAntony Ceasar Stanislaus
Antony Ceasar Stanislaus
VRVinothkumar Rajan
Vinothkumar Rajan
SPSergey V. Prykhozhij
Sergey V. Prykhozhij
JBJason N. Berman
Jason N. Berman
SS. Ignacimuthu
S. Ignacimuthu

5 March 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SPSergey Prykhozhij
Sergey Prykhozhij
VRVinothkumar Rajan
Vinothkumar Rajan
DGDaniel Gaston
Daniel Gaston
JBJason N Berman
Jason N Berman
Genome engineering has been revolutionized by the discovery of clustered regularly interspaced palindromic repeats (CRISPR) and CRISPR-associated system genes (Cas) in bacteria. The type IIB Streptococcus pyogenes CRISPR/Cas9 system functions in many species and additional types of CRISPR/Cas systems are under development. In the type II system, expression of CRISPR single guide RNA (sgRNA) targeting a defined sequence and Cas9 generates a sequence-specific nuclease inducing small deletions or insertions. Moreover, knock-in of large DNA inserts has been shown at the sites targeted by sgRNAs and Cas9. Several tools are available for designing sgRNAs that target unique locations in the genome. However, the ability to find sgRNA targets common to several similar sequences or, by contrast, unique to each of these sequences, would also be advantageous. To provide such a tool for several types of CRISPR/Cas system and many species, we developed the CRISPR MultiTargeter software. Similar DNA sequences in question are duplicated genes and sets of exons of different transcripts of a gene. Thus, we implemented a basic sgRNA target search of input sequences for single-sgRNA and two-sgRNA/Cas9 nickase targeting, as well as common and unique sgRNA target searches in 1) a set of input sequences; 2) a set of similar genes or transcripts; or 3) transcripts a single gene. We demonstrate potential uses of the program by identifying unique isoform-specific sgRNA sites in 71% of zebrafish alternative transcripts and common sgRNA target sites in approximately 40% of zebrafish duplicated gene pairs. The design of unique targets in alternative exons is helpful because it will facilitate functional genomic studies of transcript isoforms. Similarly, its application to duplicated genes may simplify multi-gene mutational targeting experiments. Overall, this program provides a unique interface that will enhance use of CRISPR/Cas technology.

19 December 2019 in Haematologica
Verified
Journal Article
Open access
PDF file
VRVinothkumar Rajan
Vinothkumar Rajan
NMNicole Melong
Nicole Melong
WWWing Hing Wong
Wing Hing Wong
BKBenjamin King
Benjamin King
RTR. Spencer Tong
R. Spencer Tong
JBJason N. Berman
Jason N. Berman
Xenograft models are invaluable tools in establishing the current paradigms of hematopoiesis and leukemogenesis. The zebrafish has emerged as a robust alternative xenograft model but, like mice, lack specific cytokines that mimic the microenvironment found in human patients. To address this critical gap, we generated the first humanized zebrafish that express human hematopoietic-specific cytokines (GM-CSF, SCF, and SDF1α). Termed GSS fish, these zebrafish promote survival, self-renewal and multilineage differentiation of human hematopoietic stem and progenitor cells and result in enhanced proliferation and hematopoietic niche-specific homing of primary human leukemia cells. Using error-corrected RNA sequencing, we determined that patient-derived leukemias transplanted into GSS zebrafish exhibit broader clonal representation compared to transplants into control hosts. GSS zebrafish incorporating error-corrected RNA sequencing establish a new standard for zebrafish xenotransplantation that more accurately recapitulates the human context, providing a more representative cost-effective preclinical model system for evaluating personalized response-based treatment in leukemia and therapies to expand human hematopoietic stem and progenitor cells in the transplant setting.

28 May 2015 in Leukemia
Verified
Journal Article
Closed access
PDF file
ADA P Deveau
A P Deveau
AFA M Forrester
A M Forrester
ACA J Coombs
A J Coombs
GWG S Wagner
G S Wagner
CGC Grabher
C Grabher
JBJ N Berman
J N Berman

18 December 2015 in Zebrafish
Verified
Journal Article
Closed access
SPSergey Prykhozhij
Sergey Prykhozhij
VRVinothkumar Rajan
Vinothkumar Rajan
JBJason N. Berman
Jason N. Berman
The development of clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 technology for mainstream biotechnological use based on its discovery as an adaptive immune mechanism in bacteria has dramatically improved the ability of molecular biologists to modify genomes of model organisms. The zebrafish is highly amenable to applications of CRISPR/Cas9 for mutation generation and a variety of DNA insertions. Cas9 protein in complex with a guide RNA molecule recognizes where to cut the homologous DNA based on a short stretch of DNA termed the protospacer-adjacent motif (PAM). Rapid and efficient identification of target sites immediately preceding PAM sites, quantification of genomic occurrences of similar (off target) sites and predictions of cutting efficiency are some of the features where computational tools play critical roles in CRISPR/Cas9 applications. Given the rapid advent and development of this technology, it can be a challenge for researchers to remain up to date with all of the important technological developments in this field. We have contributed to the armamentarium of CRISPR/Cas9 bioinformatics tools and trained other researchers in the use of appropriate computational programs to develop suitable experimental strategies. Here we provide an in-depth guide on how to use CRISPR/Cas9 and other relevant computational tools at each step of a host of genome editing experimental strategies. We also provide detailed conceptual outlines of the steps involved in the design and execution of CRISPR/Cas9-based experimental strategies, such as generation of frameshift mutations, larger chromosomal deletions and inversions, homology-independent insertion of gene cassettes and homology-based knock-in of defined point mutations and larger gene constructs.

4 March 2022 in British Journal of Haematology
Verified
Journal Article
Closed access
VRVinothkumar Rajan
Vinothkumar Rajan
SPSergey V. Prykhozhij
Sergey V. Prykhozhij
APAditya Pandey
Aditya Pandey
ACAlejandro M. Cohen
Alejandro M. Cohen
JRJan K. Rainey
Jan K. Rainey
JBJason N. Berman
Jason N. Berman